“It’s called GLP one receptor,” said Atul Malhotra, MD from the UC San Diego School of Medicine. It’s already FDA-approved to manage diabetes and obesity. Now, researchers at UC San Diego have gotten ...
On Tuesday, the Timmins Chamber announced the nominees for the 2025 Nova Awards celebrating Timmins businesses, entrepreneurs ...